LeonaBio
Develops lasofoxifene for metastatic breast cancer and ATH-1105 for ALS.
$7.83
After-hours close−0.17 (−2.12%)
At close$8.00(+1.39%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.69 | — | — |
| Aug 2026 | −$1.39 | −$0.80 | +42.4% |
| May 2026 | −$2.28 | −$1.73 | +24.0% |
| Mar 2026 | −$1.35 | −$18.92 | −1,300.3% |
| Nov 2025 | −$1.06 | −$1.68 | −58.5% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.69 | — | — | — | — | — |
| Aug 14, 2026 | −$1.39 | −$0.80 | +42.4% | — | — | — |
| May 7, 2026 | −$2.28 | −$1.73 | +24.0% | — | — | — |
| Mar 26, 2026 | −$1.35 | −$18.92 | −1,300.3% | — | — | — |
| Nov 6, 2025 | −$1.06 | −$1.68 | −58.5% | — | — | — |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 9, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 15, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 24, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 25, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Sep 18, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||